SOUTH SAN FRANCISCO, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of ...
Hanan Qasim, the first author of the study and Bradley McConnell, University of Houston professor of pharmacology, are reporting a new therapuetic target to treat heart failure. Researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback